Objective: To identify the levels of therapeutic adherence in patients with diabetes mellitus II (DMII), their knowledge and beliefs about the disease and its treatment. Methodology: This was a mixed study in people from a city in northeastern Mexico, a questionnaire on beliefs about adherence in people with diabetes was applied. A questionnaire of 11 open questions was also applied to 45 people diagnosed with IBD. Results: 42.22% of people have a high adherence to medication, adherence to emotional management and exercise is low (37. 77% and 28.88%, respectively ). 39. 64% of people attribute the origin of the disease to habits and 22.41% to genetic heritage. Conclusions: Diabetes mellitus is shown as an illness unknown to patients, in rel...
Antecedentes: la diabetes mellitus tipo 2 (DM2) es una causa importante de morbi-mortalidad a nivel...
RESUMENEl propósito de la investigación fue examinar la contribución de la variable personalidad en ...
The Scale for Treatment Adherence in Type 2 Diabetes Mellitus - version III (EATDM-III©) was tested....
Objective: To identify the levels of therapeutic adherence in patients with diabetes mellitus II (DM...
Objective: To develop an instrument to identify beliefs and therapeutic adherence. Methodology: Mixe...
Objective: To assess whether knowledge about type II diabetes mellitus (T2DM) is associated with adh...
Objective: To assess whether knowledge about Diabetes Mellitus (DM), family functionality and depres...
Antecedentes: la Diabetes Mellitus, es una de las enfermedades que es considerada un problema de sal...
To analyze the perception of empowerment and therapeutic adherence in patients with Type 2 Diabetes ...
Background: it examines and describes the style of life in patients with type 2 diabetes mellitus, w...
La diabetes es conocida como enfermedad crónica que afecta a las personas cuando el cuerpo no produc...
INTRODUCTION: Noncommunicable diseases are a public health problem, increasing amounts the number of...
2020 chronic diseases are the leading cause of disability, and by 2030 the incidence will double in ...
Antecedentes: se examina y describe el estilo de vida de pacientes con Diabetes mellitus tipo 2, los...
Introduction: Diabetes Mellitus is a condition that begins when the pancreas does not make proper us...
Antecedentes: la diabetes mellitus tipo 2 (DM2) es una causa importante de morbi-mortalidad a nivel...
RESUMENEl propósito de la investigación fue examinar la contribución de la variable personalidad en ...
The Scale for Treatment Adherence in Type 2 Diabetes Mellitus - version III (EATDM-III©) was tested....
Objective: To identify the levels of therapeutic adherence in patients with diabetes mellitus II (DM...
Objective: To develop an instrument to identify beliefs and therapeutic adherence. Methodology: Mixe...
Objective: To assess whether knowledge about type II diabetes mellitus (T2DM) is associated with adh...
Objective: To assess whether knowledge about Diabetes Mellitus (DM), family functionality and depres...
Antecedentes: la Diabetes Mellitus, es una de las enfermedades que es considerada un problema de sal...
To analyze the perception of empowerment and therapeutic adherence in patients with Type 2 Diabetes ...
Background: it examines and describes the style of life in patients with type 2 diabetes mellitus, w...
La diabetes es conocida como enfermedad crónica que afecta a las personas cuando el cuerpo no produc...
INTRODUCTION: Noncommunicable diseases are a public health problem, increasing amounts the number of...
2020 chronic diseases are the leading cause of disability, and by 2030 the incidence will double in ...
Antecedentes: se examina y describe el estilo de vida de pacientes con Diabetes mellitus tipo 2, los...
Introduction: Diabetes Mellitus is a condition that begins when the pancreas does not make proper us...
Antecedentes: la diabetes mellitus tipo 2 (DM2) es una causa importante de morbi-mortalidad a nivel...
RESUMENEl propósito de la investigación fue examinar la contribución de la variable personalidad en ...
The Scale for Treatment Adherence in Type 2 Diabetes Mellitus - version III (EATDM-III©) was tested....